Literature DB >> 32732252

Ovarian Cancer Risk Factor Associations by Primary Anatomic Site: The Ovarian Cancer Cohort Consortium.

Shelley S Tworoger1,2, Leo J Schouten3, Renée T Fortner4, Megan S Rice5, Synnove F Knutsen6, Michael J Orlich6, Kala Visvanathan7, Alpa V Patel8, Mia M Gaudet8, Anne Tjønneland9,10, Marina Kvaskoff11,12, Rudolf Kaaks13, Antonia Trichopolou14, Valeria Pala15, N Charlotte Onland-Moret16, Inger T Gram17, Pilar Amiano18,19, Annika Idahl20, Naomi E Allen21, Elisabete Weiderpass22, Jenny N Poynter23, Kim Robien24, Graham G Giles25,26,27, Roger L Milne25,26,27, Veronica W Setiawan28, Melissa A Merritt29, Piet A van den Brandt30, Anne Zeleniuch-Jacquotte31, Alan A Arslan31, Katie M O'Brien32, Dale P Sandler32, Alicja Wolk33,34, Niclas Håkansson33, Holly R Harris35,36, Britton Trabert37, Nicolas Wentzensen37.   

Abstract

BACKGROUND: Epithelial ovarian, fallopian tube, and primary peritoneal cancers have shared developmental pathways. Few studies have prospectively examined heterogeneity in risk factor associations across these three anatomic sites.
METHODS: We identified 3,738 ovarian, 337 peritoneal, and 176 fallopian tube incident cancer cases in 891,731 women from 15 prospective cohorts in the Ovarian Cancer Cohort Consortium. Associations between 18 putative risk factors and risk of ovarian, peritoneal, and fallopian tube cancer, overall and for serous and high-grade serous tumors, were evaluated using competing risks Cox proportional hazards regression. Heterogeneity was assessed by likelihood ratio tests.
RESULTS: Most associations did not vary by tumor site (P het ≥ 0.05). Associations between first pregnancy (P het = 0.04), tubal ligation (P het = 0.01), and early-adult (age 18-21 years) body mass index (BMI; P het = 0.02) and risk differed between ovarian and peritoneal cancers. The association between early-adult BMI and risk further differed between peritoneal and fallopian tube cancer (P het = 0.03). First pregnancy and tubal ligation were inversely associated with ovarian, but not peritoneal, cancer. Higher early-adult BMI was associated with higher risk of peritoneal, but not ovarian or fallopian tube, cancer. Patterns were generally similar when restricted to serous and high-grade serous cases.
CONCLUSIONS: Ovarian, fallopian tube, and primary peritoneal cancers appear to have both shared and distinct etiologic pathways, although most risk factors appear to have similar associations by anatomic site. IMPACT: Further studies on the mechanisms underlying the differences in risk profiles may provide insights regarding the developmental origins of tumors arising in the peritoneal cavity and inform prevention efforts. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2020        PMID: 32732252      PMCID: PMC7541500          DOI: 10.1158/1055-9965.EPI-20-0354

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  28 in total

Review 1.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms.

Authors:  Eugenia E Calle; Rudolf Kaaks
Journal:  Nat Rev Cancer       Date:  2004-08       Impact factor: 60.716

2.  Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.

Authors:  Britton Trabert; Ligia Pinto; Patricia Hartge; Troy Kemp; Amanda Black; Mark E Sherman; Louise A Brinton; Ruth M Pfeiffer; Meredith S Shiels; Anil K Chaturvedi; Allan Hildesheim; Nicolas Wentzensen
Journal:  Gynecol Oncol       Date:  2014-08-23       Impact factor: 5.482

3.  Parity, tubal sterilization, hysterectomy and risk of primary fallopian tube carcinoma in Finland, 1975-2004.

Authors:  Annika Riska; Reijo Sund; Eero Pukkala; Mika Gissler; Arto Leminen
Journal:  Int J Cancer       Date:  2007-03-15       Impact factor: 7.396

4.  Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer.

Authors:  G H Eltabbakh; M S Piver; N Natarajan; C J Mettlin
Journal:  Obstet Gynecol       Date:  1998-02       Impact factor: 7.661

5.  Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium.

Authors:  Jennifer Ose; Elizabeth M Poole; Helena Schock; Matti Lehtinen; Alan A Arslan; Anne Zeleniuch-Jacquotte; Kala Visvanathan; Kathy Helzlsouer; Julie E Buring; I-Min Lee; Anne Tjønneland; Laure Dossus; Antonia Trichopoulou; Giovanna Masala; N Charlotte Onland-Moret; Elisabete Weiderpass; Eric J Duell; Annika Idahl; Ruth C Travis; Sabina Rinaldi; Melissa A Merritt; Britton Trabert; Nicolas Wentzensen; Shelley S Tworoger; Rudolf Kaaks; Renée T Fortner
Journal:  Cancer Res       Date:  2017-04-05       Impact factor: 12.701

6.  Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.

Authors:  V Beral; R Doll; C Hermon; R Peto; G Reeves
Journal:  Lancet       Date:  2008-01-26       Impact factor: 79.321

7.  A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer.

Authors:  Elizabeth M Poole; I-Min Lee; Paul M Ridker; Julie E Buring; Susan E Hankinson; Shelley S Tworoger
Journal:  Am J Epidemiol       Date:  2013-08-21       Impact factor: 4.897

8.  Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin?

Authors:  Michael H Roh; David Kindelberger; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2009-03       Impact factor: 6.394

9.  Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies.

Authors:  Weiva Sieh; Shannon Salvador; Valerie McGuire; Rachel Palmieri Weber; Kathryn L Terry; Mary Anne Rossing; Harvey Risch; Anna H Wu; Penelope M Webb; Kirsten Moysich; Jennifer A Doherty; Anna Felberg; Dianne Miller; Susan J Jordan; Marc T Goodman; Galina Lurie; Jenny Chang-Claude; Anja Rudolph; Susanne Krüger Kjær; Allan Jensen; Estrid Høgdall; Elisa V Bandera; Sara H Olson; Melony G King; Lorna Rodriguez-Rodriguez; Lambertus A Kiemeney; Tamara Marees; Leon F Massuger; Anne M van Altena; Roberta B Ness; Daniel W Cramer; Malcolm C Pike; Celeste Leigh Pearce; Andrew Berchuck; Joellen M Schildkraut; Alice S Whittemore
Journal:  Int J Epidemiol       Date:  2013-04       Impact factor: 7.196

10.  Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.

Authors:  Susan J Jordan; Adèle C Green; David C Whiteman; Suzanne P Moore; Christopher J Bain; Dorota M Gertig; Penelope M Webb
Journal:  Int J Cancer       Date:  2008-04-01       Impact factor: 7.396

View more
  2 in total

1.  Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3).

Authors:  Mary K Townsend; Britton Trabert; Renée T Fortner; Alan A Arslan; Julie E Buring; Brian D Carter; Graham G Giles; Sarah R Irvin; Michael E Jones; Rudolf Kaaks; Victoria A Kirsh; Synnove F Knutsen; Woon-Puay Koh; James V Lacey; Hilde Langseth; Susanna C Larsson; I-Min Lee; María Elena Martínez; Melissa A Merritt; Roger L Milne; Katie M O'Brien; Michael J Orlich; Julie R Palmer; Alpa V Patel; Ulrike Peters; Jenny N Poynter; Kim Robien; Thomas E Rohan; Lynn Rosenberg; Sven Sandin; Dale P Sandler; Leo J Schouten; V Wendy Setiawan; Anthony J Swerdlow; Giske Ursin; Piet A van den Brandt; Kala Visvanathan; Elisabete Weiderpass; Alicja Wolk; Jian-Min Yuan; Anne Zeleniuch-Jacquotte; Shelley S Tworoger; Nicolas Wentzensen
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

2.  Obesity and gynecological cancers: A toxic relationship.

Authors:  Ignacio A Wichmann; Mauricio A Cuello
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.